• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性 TRAIL 作为变应性鼻炎结膜炎患者变应原特异性免疫治疗疗效的标志物。

Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis.

机构信息

Internal Medicine, Allergology and Clinical Immunology Unit, Antalya Education and Research Hospital, Antalya, Turkey.

出版信息

Med Sci Monit. 2012 Oct;18(10):CR617-21. doi: 10.12659/msm.883488.

DOI:10.12659/msm.883488
PMID:23018355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3560552/
Abstract

BACKGROUND

Allergic rhinitis is a common health problem affecting the immune system. The homeostasis of the immune system is regulated by apoptosis. In this study, serum circulating soluble TRAIL levels of allergic rhinoconjunctivitis patients before and after allergen-specific immunotherapy were evaluated.

MATERIAL/METHODS: The sTRAIL levels of pre- and post-treated allergic rhinoconjunctivitis patients (n=25) were compared to age- and sex-matched healthy individuals (n=25). sTRAIL levels were measured by ELISA. The skin prick test (SPT) results were recorded before and after treatment.

RESULTS

The sTRAIL levels between the pre-treated and control groups were significantly different (p<0.0001). However, there was no significant difference between the post-treated group and healthy individuals (p=0,801). SPT was a statistically significant difference between the values of the research group before and after immunotherapy (grasses mixture, barley mixture, Oleaauropeae, D. Pteronyssinus, D. farinae).

CONCLUSIONS

The sTRAIL levels were decreased after allergen-specific immunotherapy to healthy levels and may be of use as a marker of efficacy of immunotherapy in allergic rhinoconjunctivitis patients.

摘要

背景

变应性鼻炎是一种常见的影响免疫系统的健康问题。免疫系统的动态平衡受细胞凋亡调节。在这项研究中,评估了变应性鼻结膜炎患者在变应原特异性免疫治疗前后血清中循环可溶性 TRAIL 水平。

材料/方法:将治疗前后的变应性鼻结膜炎患者(n=25)的 sTRAIL 水平与年龄和性别匹配的健康个体(n=25)进行比较。通过 ELISA 测量 sTRAIL 水平。记录治疗前后的皮肤点刺试验(SPT)结果。

结果

治疗前组与对照组之间的 sTRAIL 水平差异有统计学意义(p<0.0001)。然而,治疗后组与健康个体之间无显著差异(p=0.801)。SPT 在免疫治疗前后的研究组之间有统计学显著差异(草混合物、大麦混合物、橄榄属、D. Pteronyssinus、D. farinae)。

结论

变应原特异性免疫治疗后 sTRAIL 水平降低至健康水平,可能作为变应性鼻结膜炎患者免疫治疗疗效的标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a58a/3560552/e0cdc4fef89f/medscimonit-18-10-CR617-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a58a/3560552/e0cdc4fef89f/medscimonit-18-10-CR617-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a58a/3560552/e0cdc4fef89f/medscimonit-18-10-CR617-g001.jpg

相似文献

1
Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis.可溶性 TRAIL 作为变应性鼻炎结膜炎患者变应原特异性免疫治疗疗效的标志物。
Med Sci Monit. 2012 Oct;18(10):CR617-21. doi: 10.12659/msm.883488.
2
Cc-chemokine eotaxin as a marker of efficacy of specific immunotherapy in patients with intermittent IgE-mediated allergic rhinoconjunctivitis.
Allergy. 2003 Jul;58(7):595-601. doi: 10.1034/j.1398-9995.2003.00083.x.
3
Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial.花粉诱导的鼻结膜炎的淋巴内免疫疗法:一项双盲安慰剂对照试验。
Respir Res. 2016 Jan 27;17:10. doi: 10.1186/s12931-016-0324-9.
4
Seasonal Local Allergic Rhinitis in Areas With High Concentrations of Grass Pollen.草花粉浓度高的地区的季节性局部过敏性鼻炎
J Investig Allergol Clin Immunol. 2016;26(2):83-91. doi: 10.18176/jiaci.0018.
5
Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.每日一次舌下含服草花粉变应原片剂免疫疗法:季节性变应性鼻结膜炎的一项随机对照试验
J Allergy Clin Immunol. 2006 Apr;117(4):802-9. doi: 10.1016/j.jaci.2005.12.1358.
6
Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization.对因橄榄花粉致敏而患有变应性鼻结膜炎和轻度哮喘的儿科患者,采用标准化橄榄花粉提取物进行舌下免疫疗法的双盲、安慰剂对照评估。
Allergy. 1998 Jul;53(7):662-72. doi: 10.1111/j.1398-9995.1998.tb03952.x.
7
The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity.使用分子标准化草和黑麦过敏原的短期免疫疗法与对症药物治疗相比,对鼻结膜炎症状、皮肤敏感性和特定鼻反应性的影响。
Otolaryngol Head Neck Surg. 2005 Oct;133(4):538-43. doi: 10.1016/j.otohns.2005.07.020.
8
Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis.标准化墙草提取物舌下含服-吞咽免疫疗法治疗儿童变应性鼻结膜炎的双盲安慰剂对照评估
J Allergy Clin Immunol. 1999 Aug;104(2 Pt 1):425-32. doi: 10.1016/s0091-6749(99)70388-x.
9
Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.舌下免疫治疗尘螨单致敏变应性鼻结膜炎儿童的双盲安慰剂对照随机试验。
Respir Med. 2013 Sep;107(9):1322-9. doi: 10.1016/j.rmed.2013.06.021. Epub 2013 Jul 23.
10
300IR 5-Grass pollen sublingual tablet offers relief from nasal symptoms in patients with allergic rhinitis.300IR 5 - 草花粉舌下片可缓解过敏性鼻炎患者的鼻部症状。
Am J Rhinol Allergy. 2014 Nov-Dec;28(6):471-6. doi: 10.2500/ajra.2014.28.4112. Epub 2014 Oct 20.

引用本文的文献

1
Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.血清TRAIL和DR5水平升高与稳定期慢性阻塞性肺疾病(COPD)患者的肺功能及炎症相关。
Int J Chron Obstruct Pulmon Dis. 2015 Nov 6;10:2405-12. doi: 10.2147/COPD.S92260. eCollection 2015.
2
An overview of the effects of anti-IgE therapies.抗IgE疗法的效果概述。
Med Sci Monit. 2014 Sep 22;20:1691-9. doi: 10.12659/MSM.890137.
3
Molecular biomarkers for grass pollen immunotherapy.草花粉免疫疗法的分子生物标志物。

本文引用的文献

1
Increased serum S-TRAIL level in newly diagnosed stage-IV lung adenocarcinoma but not squamous cell carcinoma is correlated with age and smoking.新诊断的IV期肺腺癌患者血清S-TRAIL水平升高,但肺鳞癌患者并非如此,且血清S-TRAIL水平升高与年龄和吸烟相关。
Asian Pac J Cancer Prev. 2013;14(8):4819-22. doi: 10.7314/apjcp.2013.14.8.4819.
2
IL-8, IL-10, TGF-β, and GCSF levels were increased in severe persistent allergic asthma patients with the anti-IgE treatment.白细胞介素-8(IL-8)、白细胞介素-10(IL-10)、转化生长因子-β(TGF-β)和粒细胞集落刺激因子(GCSF)水平在接受抗 IgE 治疗的严重持续性过敏性哮喘患者中升高。
Mediators Inflamm. 2012;2012:720976. doi: 10.1155/2012/720976. Epub 2012 Dec 19.
3
World J Methodol. 2014 Mar 26;4(1):26-45. doi: 10.5662/wjm.v4.i1.26.
4
[Specific immunotherapy].[特异性免疫疗法]
Hautarzt. 2014 Jul;65(7):633-45; quiz 646-7. doi: 10.1007/s00105-014-2817-0.
5
Implementation of validated pharmacodynamic assays in multiple laboratories: challenges, successes, and limitations.在多个实验室中实施经过验证的药效学检测:挑战、成功经验与局限性
Clin Cancer Res. 2014 May 15;20(10):2578-86. doi: 10.1158/1078-0432.CCR-14-0476.
6
Pollen aero allergens and the climate in Mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients.花粉气传过敏原与地中海地区气候及变应性鼻炎-结膜炎和变应性哮喘患者变应原敏感性的关系。
Med Sci Monit. 2013 Feb 11;19:102-10. doi: 10.12659/msm.883762.
The relation of sTRAIL levels and quality of life in severe persistent allergic asthma patients using omalizumab.
使用奥马珠单抗的重度持续性过敏性哮喘患者中可溶性肿瘤坏死因子相关凋亡诱导配体(sTRAIL)水平与生活质量的关系。
Med Sci Monit. 2012 Aug;18(8):LE9-10. doi: 10.12659/msm.883249.
4
Systemic levels of ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis.变应性哮喘和变应性鼻炎患者血清铜蓝蛋白氧化酶活性的系统水平。
Immunopharmacol Immunotoxicol. 2012 Dec;34(6):1047-53. doi: 10.3109/08923973.2012.697902. Epub 2012 Jun 28.
5
Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients.循环可溶性肿瘤坏死因子相关凋亡诱导配体(TRAIL)在新诊断的 2 型、非药物使用的糖尿病患者中降低。
Diabetes Res Clin Pract. 2012 Jun;96(3):e84-6. doi: 10.1016/j.diabres.2012.02.028. Epub 2012 Mar 23.
6
Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment.重度持续性过敏性哮喘患者的总抗氧化能力、过氧化氢、丙二醛和总一氧化氮浓度:其与奥马珠单抗治疗的关系。
Clin Lab. 2012;58(1-2):89-96.
7
Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: its relation to omalizumab treatment.严重持续性过敏性哮喘患者血清可溶性 TRAIL 水平:与奥马珠单抗治疗的关系。
Med Sci Monit. 2012 Mar;18(3):PI11-5. doi: 10.12659/msm.882504.
8
Sensitization profiles in polysensitized patients from a restricted geographical area: further lessons from multiplexed component resolved diagnosis.来自特定地理区域的多敏患者的致敏谱:多重成分分辨诊断的更多经验教训
Eur Ann Allergy Clin Immunol. 2011 Dec;43(6):171-5.
9
Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer.血清 sTRAIL 水平升高与贝伐珠单抗治疗转移性结直肠癌的生存相关。
BMC Cancer. 2012 Feb 7;12:58. doi: 10.1186/1471-2407-12-58.
10
TRAIL mediated signaling in human mast cells: the influence of IgE-dependent activation.肿瘤坏死因子相关凋亡诱导配体介导的人肥大细胞信号传导:IgE 依赖性激活的影响。
Allergy. 2008 Mar;63(3):333-40. doi: 10.1111/j.1398-9995.2007.01598.x.